MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hughes, R. J.
Right arrow Articles by Insel, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughes, R. J.
Right arrow Articles by Insel, P. A.

Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptor metabolism in a muscle cell line, BC3H-1

RJ Hughes and PA Insel

We have compared the metabolism of alpha 1- and beta 2-adrenergic receptors which are both expressed in BC3H-1 muscle cells. During growth of the cells to confluence, the number of alpha 1-receptors per mg of membrane protein increases, whereas that of the beta 2-receptors remains constant. Experiments using cycloheximide and irreversible alpha 1- and beta 2-receptor antagonists, phenoxybenzamine and N-[2- hydroxy-3-(1-naphthoxy)-propyl]-N'-bromoacetylethylenediamine , respectively, yield disparate turnover rates (t1/2) for the two receptors: alpha 1 congruent to 25 hr, beta 2 congruent to 200 hr. These experiments suggest that synthesis of beta 2-receptors virtually ceases in confluent cells. Maximally effective doses of agonists down- regulated both receptor types 80-90% and enhanced the rates of loss of both receptors (t1/2 = 1-5 hr). The rates of down-regulation were not affected by cycloheximide, implying that agonists enhance receptor clearance rather than decrease receptor appearance. The rank orders of potencies of agonists for promoting receptor down-regulation were those characteristic of alpha 1- and beta 2-receptors. However, concentrations of agonists that resulted in down-regulation of each receptor subtype were 10- to 100-fold lower than those required for occupancy of receptors as assessed in radioligand binding studies. Receptor recovery following removal of agonists was blocked by cycloheximide and was much faster than the recovery that followed treatment of cells with irreversible antagonists. Therefore, protein synthesis (but perhaps not receptor synthesis per se) appears necessary for recovery from down-regulation. In addition, the rates of recovery of alpha 1- and beta 2-receptor-mediated functions (phosphatidylinositol turnover and cyclic AMP synthesis, respectively) following receptor down-regulation or irreversible blockade parallel the rates of receptor recovery. These data indicate that basal metabolism of alpha 1- and beta 2-receptors in BC3H-1 cells is substantially different, but that agonist-mediated changes in metabolism of the two receptor subtypes are similar. Thus, common mechanisms appear to mediate the regulation by agonists of alpha 1- and beta 2-receptors in these cells.

Volume 29, Issue 6, pp. 521-530, 06/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
T. Awaji, A. Hirasawa, M. Kataoka, H. Shinoura, Y. Nakayama, T. Sugawara, S.-i. Izumi, and G. Tsujimoto
Real-Time Optical Monitoring of Ligand-Mediated Internalization of {alpha}1b-Adrenoceptor with Green Fluorescent Protein
Mol. Endocrinol., August 1, 1998; 12(8): 1099 - 1111.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. I. Fonseca, D. C. Button, and R. D. Brown
Agonist Regulation of [IMAGE][IMAGE]-Adrenergic Receptor Subcellular Distribution and Function
J. Biol. Chem., April 14, 1995; 270(15): 8902 - 8909.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1986 by the American Society for Pharmacology and Experimental Therapeutics